RecruitingNCT07348289

PIVO Use for Blood Cultures in the Emergency Department

PIVO-ED: Protocol for Intermountain Venous Access Optimization for Blood Cultures in the Emergency Department


Sponsor

Intermountain Health Care, Inc.

Enrollment

10,000 participants

Start Date

Oct 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators will implement a protocol for use of the PIVO device for blood culture collection in the emergency department. This protocol utilizes the device in various scenarios to reduce needlesticks while allowing for accurate and appropriate assessment of potential pathogens in the bloodstream. The study team will train staff on use of the device then monitor utilization and contamination rates among emergency department patients.


Eligibility

Inclusion Criteria1

  • \-

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPIVO device, a needle-free blood draw device

The PIVO device, a needle-free blood draw device, may be used through an IV to obtain a blood sample and extends beyond the IV to ideally reduce the potential for contamination and to improve success in obtaining a sample. Per Google AI: "PIVO™ by Velano Vascular stands for Peripheral IV Origin, a needle-free blood draw device that uses a patient's existing peripheral IV (PIV) line to collect blood, avoiding extra needle sticks and reducing pain, hemolysis, and contamination, facilitating the "One-Stick Hospital Stay" goal for better patient care."


Locations(1)

Park City Hospital

Park City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07348289


Related Trials